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A synthetic route to enantiopure cis-2,4-disubstituted and 
2,4-bridged piperidines is reported, the key step being a 
stereoselective conjugate addition of an organocuprate to a 
phenylglycinol-derived unsaturated lactam bearing a 
substituent at the 8a-position. 
Aminoalcohol-derived oxazolopiperidone lactams are 
exceptionally versatile building blocks for the enantioselective 
construction of structurally diverse piperidine-containing 
natural products and bioactive compounds.1 These lactams 
allow the substituents to be introduced at the different ring 
positions in a regio- and stereocontrolled manner, providing 
easy access to enantiopure polysubstituted piperidines bearing 
virtually any type of substitution pattern.2 In particular, the 
conjugate addition to α,β-unsaturated oxazolopiperidone 
lactams allows the stereocontrolled formation of a C–C bond 
at the piperidine 4-position, and has successfully been used to 
generate either cis or trans 3,4-disubstituted enantiopure 
piperidine-containing derivatives, including the antidepressant 
drug (–)-paroxetine,3 cis-fused perhydrocycloalka[c]pyri-
dines,4 and the indole alkaloid (+)-uleine.5
  
To further expand the potential of these lactams we decided 
to explore a synthetic route to enantiopure 2,4-bridged 
piperidine derivatives, as outlined in Scheme 1. The key step 
would be the stereocontrolled introduction of an appropriate 
unsaturated chain at the 4-position of the piperidine ring by 
conjugated addition of an organocuprate to an unsaturated 
lactam A bearing an unsaturated substituent at the 2-position. 
A subsequent ring-closing metathesis from the resulting cis-
2,4-disubstituted piperidine derivative would lead to the target 
bridged azabicyclo. 
 
SCHEME 1. Synthetic Strategy 
 
 
 
It has previously been established6 that the conjugate 
addition of organocuprates to unsaturated oxazolopiperidone 
lactams B (when R = H) is highly stereoselective as a 
consequence of the conformational rigidity of the bicyclic 
system. The nucleophilic attack occurs under stereoelectronic 
control7 on the exo face, axial to the electrophilic carbon of the 
conjugate double bond (Figure 1).8 However, it could be 
expected9 a priori that the presence of a substituent at the 
angular position (R ≠ H)  could  alter  the  stereochemical  
outcome  of  the conjugate addition as a consequence of the 
1,3-syn diaxial interactions between this substituent and the 
incoming nucleophile. For this reason, to evaluate the viability 
of our synthetic plan we decided to carry out a preliminary 
study on the stereoselectivity of similar conjugate addition 
reactions from the model, more easily accessible, unsaturated 
lactams 3a and 3b. These lactams were prepared,10 via the 
corresponding selenides 2 (diastereomeric mixtures), from the 
known lactams 1a and 1b11  (Scheme 2). The easily removable 
benzyloxy-carbonyl electron-withdrawing group was used to 
enhance the reactivity of the conjugated system.12 
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FIGURE 1. Stereoelectronic control in the conjugate addition. 
 
The conjugate addition of a vinyl group to lactam 3a was 
satisfactorily accomplished (62% overall yield from 2a) with 
vinylmagnesium bromide in the presence of LiCl, CuI, and 
trimethylsilyl chloride13 in THF. The high exo facial 
stereoselectivity of the conjugate addition was confirmed after 
removal of the benzyloxycarbonyl substituent present in 4a by 
hydrogenolysis, which took place with simultaneous 
hydrogenation of the vinyl group, followed by thermal 
decarboxylation. Under these conditions a 93:7 mixture 
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(calculated by NMR) of lactam 7a and its C-7 epimer was 
obtained (see Table 1). 
 
SCHEME 2. Conjugate Addition to 8a-Substituted 
Unsaturated Oxazolopiperidone Lactams 
 
 
 
 
Under the same conditions the sterically more demanding 
8a-phenyl substituted lactam 3b gave a similar result: the 
conjugate addition of a vinyl residue took place in 61% yield 
(from 2b) and the subsequent debenzyloxycarbonylation 
afforded (73%) a 94:6 diastereomeric mixture of 7b and its C-
7 epimer. 
Similar conjugate additions of allylmagnesium chloride to 
unsaturated lactams 3a and 3b took place with lower 
stereoselectivity and, after removal of the benzyloxycarbonyl 
group as  in the above series, lactams 8a and 8b were obtained 
along with the corresponding C-7 epimers (78:22 and 85:15 
ratio, respectively) in acceptable overall yield (50% from 2a; 
65% from 2b). 
A moderate stereoselectivity was also observed in the 
conjugate addition of the organocuprate derived from 
phenylmagnesium chloride to 3a: a 84:16 mixture of lactam 
9a and its C-7 epimer was isolated in 51% overall yield from 
2a. 
In contrast, somewhat surprisingly, the conjugate addition 
of this organocuprate to the 8a-phenyl substituted lactam 3b 
took place in excellent yield and very high exo 
stereoselectivity (Table 1), ultimately leading to lactam 9b in 
60% overall yield (from 2b). A pi–stacking interaction 
between the incoming- and 8a-phenyl groups could account 
for the high stereoselectivity. 
 
TABLE 1. Conjugate Addition Reactions from 
Unsaturated Lactams 3 
unsaturated 
lactam 
 
product 
yield  
(%)a 
R1/R2 cis:trans 
ratiob 
3a 4a 62 93:7 
3a 5a 70 78:22 
3a 6a 74 85:16 
3b 4b 61 94:6 
3b 5b 91 85:15 
3b 6b 72 92:8 
a
 Overall yield from selenides 2. b Calculated by NMR after 
debenzyloxycarbonylation 
To illustrate the synthetic usefulness of the above 
methodology, the phenyl-substituted lactams 9a and 9b were 
converted to enantiopure cis-2,4-disubstituted piperidines as 
shown in Scheme 3. Thus, treatment of lactams 9 with LiAlH4 
brought about both the reduction of the amide carbonyl group 
and the reductive opening of the oxazolidine ring, which took 
place with complete retention of configuration,14 to give 
piperidines 10a and 10b. The cis-relationship of the piperidine 
substituents at C-2 and C-4 in 10 was evident from the 
multiplicity of the axial 2 and 4 protons in the NMR spectra 
(see Supporting Information), thus confirming the 
stereochemical outcome of the above conjugate additions. A 
subsequent debenzylation in the presence of (Boc)2O gave 
enantiopure piperidines 11a and 11b. 
 
 
SCHEME 3. Synthesis of Enantiopure cis-2,4-Disubstituted 
Piperidines 
 
 
 
 
The above results made evident that the presence of a 
substituent at the angular 8a-position has little effect on the 
stereoselectivity of the conjugate addition. However, to access 
bridged piperidine derivatives following the strategy outlined 
in Scheme 1, we decided to take advantage of the higher 
stereoselectivity of the vinyl conjugate additions and chose 
starting lactams A bearing an allyl or 3-butenyl substituent at 
the 8a-position, which should ultimately lead to 6,6 and 6,7 
bridged azabicyclic systems, respectively. 
The synthetic sequence is outlined in Scheme 4. The 
required unsaturated lactams 14
10
 were prepared from lactams 
12a15 and 12b16 via the corresponding selenides 13. As could 
be expected from the above model experiments, the conjugate 
addition of the organocuprate derived from vinylmagnesium 
bromide to crude lactams 14 took place in good yield (~60% 
from 13) and excellent facial diastereoselectivity to give the 
exo compounds 15 as C-6 epimeric mixtures (only trace 
amounts of C-7 endo epimers were detected by NMR), which 
were directly cyclized (~80% yield) in the presence of the 
second generation Grubbs catalyst.17 A subsequent catalytic 
hydrogenation of the resulting bridged derivatives 16 brought 
about both the reduction of the C–C double bond and 
debenzylation to lead, after thermal decarboxylation, to 
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tricyclic lactams 17a (78%) and 17b (83%). In the 6,7 bridged 
series, lactam 17b was converted to the enantiopure 7-
azabicyclo[4.3.1]decane (B-homomorphan) 19b (58% overall 
yield) by alane reduction followed by hydrogenolysis in 
presence of (Boc)2O.
18 However, in 17a the reductive cleavage 
of the C-O bond of the oxazolidine ring was more difficult, 
probably because the process involves the bridgehead carbon 
of a 6,6 bridged system. In this series, alane reduction of 17a 
caused only the reduction of the lactam carbonyl. A 
subsequent prolonged (48 h) treatment of the resulting 
tricyclic amine with Et3SiH-TiCl4 led to bicyclic amine 18a 
(48% overall yield from 17a), which was then converted to the 
enantiopure 2-azabicyclo[3.3.1]nonane (morphan) 19a as in 
the above 6,7 bridged series.19 Alternatively, in the B-
homomorphan series, tricyclic lactam 17b was converted to 
lactam 21 in two steps (65% overall yield) as depicted in 
Scheme 4. 
 
SCHEME 4. Synthesis of Enantiopure 2-
Azabicyclo[3.3.1]nonanes and 7-Azabicyclo[4.3.1]decanes 
 
 
 
In summary, the exo facial stereoselectivity observed in the 
conjugate addition of organocuprates to 8a-unsubstituted 
unsaturated oxazolopiperidone lactams B (R = H) is 
maintained in the 8a-substituted derivatives, in particular 
when the incoming group is vinyl. By choosing the 
appropriate substituent at the 8a position in the starting 
oxazolopiperidone and the appropriate organocuprate in the 
conjugate addition step, the reported methodology provides a 
versatile route to enantiopure cis-2,4-disubstituted and 2,4-
bridged piperidines.20 
 
Experimental Section 
 
General Procedure for the Conjugate Addition to 
Unsaturated Lactams (with 4a as an example). LiCl (189 
mg, 4.5 mmol) was heated at 80 ºC for 1 h under vacuum (10-
15 mm Hg) in a three-necked, 500 mL round-bottomed flask. 
Then, CuI (357 mg, 4.5 mmol) and THF (5 mL) were added at 
rt, and the mixture was stirred at rt for 5 min. The suspension 
was cooled at –78 ºC, and vinylmagnesium bromide (1 M in 
THF, 4.5 mL), TMSCl (0.57 mL, 4.5 mmol), and the crude of 
unsaturated lactam 3a (1.8 mmol) in THF (8 mL) were 
successively added. The resulting mixture was stirred at –78 
ºC for 20 h. The reaction was quenched with saturated 
aqueous NH4Cl, and the organic layer was extracted with 
EtOAc. The combined organic extracts were dried and 
concentrated. Flash chromatography (1:4 EtOAc-hexane) gave 
lactams 4a (major) and 7-epi-4a as mixtures of C-6 epimers 
(508 mg, 62% overall yield from 2a). 4a (major C-6 epimer): 
IR (NaCl) 1665, 1744 cm
–1
; 
1
H NMR (400 MHz, CDCl3, 
COSY, HETCOR) δ 1.54 (s, 3H, CH3), 1.94 (dd, J = 14.4, 8.4 
Hz, 1H, H-8), 2.38 (dd, J = 14.4, 7.2 Hz, 1H, H-8), 3.15 (m, 
1H, H-7), 3.40 (d, J = 10.8 Hz, 1H, H-6), 4.03 (dd, J = 9.2, 
6.8 Hz, 1H, H-2), 4.41 (t, J = 8.4 Hz, 1H, H-2), 5.09 (m, 2H, 
CH2=), 5.17 (d, J = 12.4 Hz, 1H, CH2 benzyl), 5.24 (d, J = 
12.4 Hz, 1H, CH2 benzyl), 5.42 (t, J = 7.2 Hz, 1H, H-3), 5.74 
(ddd, J = 17.2, 10.4, 7.2 Hz, 1H, CH=), 7.25-7.36 (m, 10H 
ArH); 
13
C NMR (100.6 MHz, CDCl3) δ 26.7 (CH3), 36.0 (C-
7), 39.5 (C-8), 53.7 (C-6), 59.1 (C-3), 67.0 (CH2 benzyl), 69.2 
(C-2), 93.2 (C-8a), 116.5 (CH2=), 124.5-128.5 (C-o, m, p), 
135.6, 139.7 (C-i), 138.1 (CH=), 166.7 (NCO), 168.7 (COO). 
Anal. Calcd for C24H25NO4: C, 73.64; H, 6.44; N, 3.58. 
Found: C, 73.30; H, 6.58; N, 3.51.  
 
General Procedure for the Ring-closing Metathesis 
Reaction (with 16a as an example). Second-generation 
Grubbs catalyst (3 mg) was added to a solution of lactams 15a 
(20 mg, 0.05 mmol) in CH2Cl2 (7 ml). The mixture was stirred 
at rt for 2 h, concentrated, and purified by flash column 
chromatography (1:9 to 1:4 EtOAc-hexane) to yield tricyclic 
lactam 16a as a mixture of C-6 epimers (ratio 2:1, 16 mg, 80% 
yield). 16a (major): IR (NaCl) 1659, 1734 cm
–1
; 
1
H NMR (400 
MHz, CDCl3, HETCOR) δ 2.30-2.45 (m, 3H, 2H-10, CH2), 
2.35 (dd, J = 12.0, 4.0 Hz, 1H, CH2), 3.24 (d, J = 4.0 Hz, 1H, 
H-7), 3.67 (d, J = 6.4 Hz, 1H, H-6), 4.00 (t, J = 8.8 Hz, 1H, H-
2), 4.61 (t, J = 8.4 Hz, 1H, H-2), 5.18 (d, J = 12.4 Hz, 1H, 
CH2 benzyl), 5.22 (d, J = 12.4 Hz, 1H, CH2 benzyl), 5.48 (t, J 
= 8.0 Hz, 1H, H-3), 5.64 (m, 1H, CH=), 5.76 (m, 1H, CH=), 
7.05-7.20 (m, 10H, ArH); 
13
C NMR (100.6 MHz, CDCl3) δ 
31.8 (C-10), 34.4 (C-7), 36.1 (CH2), 52.0 (C-6), 58.7 (C-3), 
67.2 (CH2 benzyl), 70.1 (C-2), 92.3 (C-11), 125.0-129.9 (C-o, 
m, p, CH=), 135.4, 139.2 (C-i), 164.2 (NCO), 169.7 (COO). 
16a (minor): 
1
H NMR (400 MHz, CDCl3, selected resonances) 
δ 2.19 (ddd, J = 12.4, 4.4, 1.6 Hz, 1H, H-10), 3.05 (br, 1H, H-
7), 3.53 (s, 1H, H-6), 4.02 (dd, J = 9.2, 7.6 Hz, 1H, H-2), 4.57 
(t, J = 8.8 Hz, 1H, H-2), 5.45 (t, J = 7.6 Hz, 1H, H-3), 5.76 
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(m, 1H, CH=), 5.90 (m, 1H, CH=); 
13
C NMR (100.6 MHz, 
CDCl3, selected resonances) δ 30.9 (C-10), 33.3 (C-7), 36.2 
(CH2), 53.5 (C-6), 57.9 (C-3), 67.0 (CH2 benzyl), 70.1 (C-2), 
92.4 (C-11), 164.5 (NCO), 168.9 (COO); HMRS calcd for 
[C24H23NO4 + H]: 390.1699, found: 390.1704. 
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